Optiver Holding
VERA icon

Optiver Holding’s Vera Therapeutics VERA Stock Holding History

Optiver Holding’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-202
Closed -$8.13K – 3102
2026
Q1 		$8.13K Sell
202
-60
-23% -$2.58K ﹤0.01% 1268
2025
Q4 		$13.3K Sell
262
-202
-44% -$7.17K ﹤0.01% 1101
2025
Q3 		$13.5K Buy
+464
New +$10.7K ﹤0.01% 1118

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Optiver Holding's VERA Position: Q2 2026 in Review

Optiver Holding sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 202 shares — an estimated $8.13K sold.

Optiver Holding first reported a position in VERA in Q3 2025 and held it in 3 quarters. The position peaked at $13.5K in Q3 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Optiver Holding reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 202 Vera Therapeutics shares in Q2 2026, an estimated $8.13K.
  • Optiver Holding first reported a position in Vera Therapeutics in Q3 2025 and held it in 3 quarters.
  • Optiver Holding's Vera Therapeutics position peaked at $13.5K in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.